Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361279813> ?p ?o ?g. }
- W4361279813 endingPage "753" @default.
- W4361279813 startingPage "753" @default.
- W4361279813 abstract "Individuals aged 65 years and above are at increased risk of complications and death from influenza compared with any other age group. Enhanced vaccines, as the MF59®-adjuvanted quadrivalent influenza vaccine (aQIV) and the high-dose quadrivalent influenza vaccine (HD-QIV), provide increased protection for older adults in comparison to the traditional standard-dose quadrivalent influenza vaccines (SD-QIV). This study aimed to assess the cost-effectiveness of aQIV compared to SD-QIV and HD-QIV in Denmark, Norway, and Sweden for adults aged ≥65 years. A static decision tree model was used to evaluate costs and outcomes of different vaccination strategies from healthcare payer and societal perspectives. This model projects that compared to SD-QIV, vaccination with aQIV could prevent a combined total of 18,772 symptomatic influenza infections, 925 hospitalizations, and 161 deaths in one influenza season across the three countries. From a healthcare payer perspective, the incremental costs per quality adjusted life year (QALY) gained with aQIV versus SD-QIV were EUR 10,170/QALY in Denmark, EUR 12,515/QALY in Norway, and EUR 9894/QALY in Sweden. The aQIV was cost saving compared with HD-QIV. This study found that introducing aQIV to the entire population aged ≥65 years may contribute to reducing the disease and economic burden associated with influenza in these countries." @default.
- W4361279813 created "2023-03-31" @default.
- W4361279813 creator A5008816108 @default.
- W4361279813 creator A5015900320 @default.
- W4361279813 creator A5016613235 @default.
- W4361279813 creator A5036869703 @default.
- W4361279813 creator A5038813701 @default.
- W4361279813 creator A5054828864 @default.
- W4361279813 creator A5059359023 @default.
- W4361279813 creator A5071201172 @default.
- W4361279813 creator A5081627175 @default.
- W4361279813 creator A5082017828 @default.
- W4361279813 creator A5082291566 @default.
- W4361279813 date "2023-03-29" @default.
- W4361279813 modified "2023-10-01" @default.
- W4361279813 title "Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden" @default.
- W4361279813 cites W1965519851 @default.
- W4361279813 cites W1971677629 @default.
- W4361279813 cites W1975597297 @default.
- W4361279813 cites W1982855609 @default.
- W4361279813 cites W1987769296 @default.
- W4361279813 cites W1991898244 @default.
- W4361279813 cites W1993279978 @default.
- W4361279813 cites W1999310725 @default.
- W4361279813 cites W2030499271 @default.
- W4361279813 cites W2033445653 @default.
- W4361279813 cites W2038316924 @default.
- W4361279813 cites W2039118188 @default.
- W4361279813 cites W2060210016 @default.
- W4361279813 cites W2101566378 @default.
- W4361279813 cites W2119758634 @default.
- W4361279813 cites W2119950877 @default.
- W4361279813 cites W2127825607 @default.
- W4361279813 cites W2129969816 @default.
- W4361279813 cites W2138536983 @default.
- W4361279813 cites W2139793607 @default.
- W4361279813 cites W2166050753 @default.
- W4361279813 cites W2168805652 @default.
- W4361279813 cites W2170533054 @default.
- W4361279813 cites W2186111569 @default.
- W4361279813 cites W2329310459 @default.
- W4361279813 cites W2412966068 @default.
- W4361279813 cites W2522063477 @default.
- W4361279813 cites W2528630108 @default.
- W4361279813 cites W2588610155 @default.
- W4361279813 cites W2606900230 @default.
- W4361279813 cites W2753149185 @default.
- W4361279813 cites W2785715721 @default.
- W4361279813 cites W2789476578 @default.
- W4361279813 cites W2791479921 @default.
- W4361279813 cites W2800582977 @default.
- W4361279813 cites W2802079007 @default.
- W4361279813 cites W2802712579 @default.
- W4361279813 cites W2890670640 @default.
- W4361279813 cites W2897465631 @default.
- W4361279813 cites W2904427385 @default.
- W4361279813 cites W2908904615 @default.
- W4361279813 cites W2912848554 @default.
- W4361279813 cites W2925528029 @default.
- W4361279813 cites W2970190413 @default.
- W4361279813 cites W3022105304 @default.
- W4361279813 cites W3030381168 @default.
- W4361279813 cites W3034798731 @default.
- W4361279813 cites W305196288 @default.
- W4361279813 cites W3092618727 @default.
- W4361279813 cites W3114025938 @default.
- W4361279813 cites W3127835162 @default.
- W4361279813 cites W3138442028 @default.
- W4361279813 cites W3161793057 @default.
- W4361279813 cites W3184515672 @default.
- W4361279813 cites W3197285268 @default.
- W4361279813 cites W3199568676 @default.
- W4361279813 cites W3206629029 @default.
- W4361279813 cites W4205820131 @default.
- W4361279813 cites W4206993024 @default.
- W4361279813 cites W4210539352 @default.
- W4361279813 cites W4210660399 @default.
- W4361279813 cites W4220892143 @default.
- W4361279813 cites W4280525815 @default.
- W4361279813 cites W4292572761 @default.
- W4361279813 cites W4293102569 @default.
- W4361279813 cites W4293724752 @default.
- W4361279813 cites W4317757171 @default.
- W4361279813 cites W577825744 @default.
- W4361279813 doi "https://doi.org/10.3390/vaccines11040753" @default.
- W4361279813 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37112667" @default.
- W4361279813 hasPublicationYear "2023" @default.
- W4361279813 type Work @default.
- W4361279813 citedByCount "4" @default.
- W4361279813 countsByYear W43612798132023 @default.
- W4361279813 crossrefType "journal-article" @default.
- W4361279813 hasAuthorship W4361279813A5008816108 @default.
- W4361279813 hasAuthorship W4361279813A5015900320 @default.
- W4361279813 hasAuthorship W4361279813A5016613235 @default.
- W4361279813 hasAuthorship W4361279813A5036869703 @default.
- W4361279813 hasAuthorship W4361279813A5038813701 @default.
- W4361279813 hasAuthorship W4361279813A5054828864 @default.
- W4361279813 hasAuthorship W4361279813A5059359023 @default.